All federal employees who collected unemployment insurance during the 16-day shutdown will have to return the payments because the workers are also receiving back pay, the Labor Department said late last week.
The agency earlier this month said it expected to issue guidance that likely would result in some states allowing federal employees to keep both the jobless benefits and the retroactive pay, depending on individual state laws.
In Oregon, for instance, a law permits employees to keep the benefits even if they receive back pay, as long as they did not perform any services during their furloughs. About 730 federal workers in Oregon made an initial claim for unemployment insurance during the shutdown and received about $390,000 in benefits, the state Employment Department says. The state paid the benefits but said it expected to be reimbursed by the federal government.
Top 5 Value Companies To Watch For 2015: Universal Health Services Inc. (UHS)
Universal Health Services, Inc., through its subsidiaries, owns and operates acute care hospitals, behavioral health centers, surgical hospitals, ambulatory surgery centers, and radiation oncology centers. The company�s hospitals offer various services comprising general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, pediatric services, pharmacy services, and/or behavioral health services. As of February 24, 2012, it owned and/or operated 25 acute care hospitals and 198 behavioral health centers located in 36 states, Puerto Rico, and the U.S. Virgin Islands, as well as Washington, D.C. The company also operates six surgical hospitals, and surgery and radiation oncology centers located in four states and Puerto Rico. Universal Health Services, Inc. was founded in 1978 and is headquartered in King of Prussia, Pennsylvania.
Advisors' Opinion:- [By Ben Levisohn]
Tenets plunge has helped drag other healthcare stocks lower.�Community Health (CYH) has dropped 3.6% to $42.21,�HCA Holdings (HCA) has fallen 2.1% to $46.72 and�Universal Health Services�(UHS) is off 1% at $80.59.
Top 5 Services Companies To Invest In Right Now: Nestle SA (NESN.VX)
Nestle SA is a Swiss Company engaged in the nutrition, health and wellness sectors. It is the holding company of the Nestle Group, which comprises subsidiaries, associated companies and joint ventures throughout the world. It has such business units as Food and Beverage, Nestle Waters and Nestle Nutrition. It is also active in the pharmaceutical sector. It divides its products into Powdered and liquid beverages, Water, Milk products and Ice cream, Nutrition, Prepared dishes and cooking aids, Confectionery, PetCare and Pharmaceutical products. In February 2011, the Company acquired CM&D Pharma Ltd.
Advisors' Opinion:- [By Michael Calia]
Post Holdings Inc.(POST) agreed to acquire the PowerBar and Musashi brands from Nestle SA(NESN.VX), further expanding the cereal maker’s position in the active nutrition category.
Top 5 Services Companies To Invest In Right Now: Chipotle Mexican Grill Inc.(CMG)
Chipotle Mexican Grill, Inc. develops and operates fast-casual, fresh Mexican food restaurants in the United States, Canada, and England. Its restaurants primarily offer burritos, tacos, burrito bowls, and salads. As of December 31, 2011, it operated 1,230 restaurants, which includes 1 ShopHouse Southeast Asian Kitchen. Chipotle Mexican Grill, Inc. was founded in 1993 and is based in Denver, Colorado.
Advisors' Opinion:- [By Nicole Seghetti]
Growth
Growth stocks aren't as stodgy as core stocks, but they aren't as sexy as aggressive. These stocks still have excellent growth potential and boast well-established business models. For example, consider a growth stock like Chipotle Mexican Grill (NYSE: CMG ) . Chipotle boasts a proven business model of providing yummy, high-quality fast food. This burrito maker has enjoyed sizzling success, but its growth story isn't over. Recently found to be the No. 1 fast-food restaurant choice among health-conscious consumers, Chipotle boasts vast growth opportunities internationally, and its Southeast Asian restaurant concept houses huge potential. - [By Charles Sizemore]
A growing, high-margin business that fits the general theme of organic fare is�Chipotle Mexican Grill (CMG), which avoids using genetically-modified food in most of its ingredients. Chipotle practically mints money with returns on equity consistently more than 20%. Chipotle also funds its expansion organically via cash flows and not via debt or share dilution.
- [By Suravi Thacker]
A company which provides a return of 593% in the span of 5 years is definitely worth watching. Chipotle Mexican Grill (CMG) is one such company which has been a commendable player in the restaurant space. Its share price has appreciated by 1297% since its inception in February 2006. The food company has been growing its presence not only through new store openings, but also through higher sales at the existing stores. This means that its comparable store sales growth has been amazing.
Top 5 Services Companies To Invest In Right Now: Trovagene Inc (TROV)
TrovaGene, Inc. (TrovaGene), incorporated on April 26, 2002, is a development-stage molecular diagnostic company that focuses on the development and marketing of urine-based nucleic acid tests for patient/disease screening and monitoring. The Company's novel tests predominantly use transrenal DNA (Tr-DNA) and transrenal RNA (Tr-RNA). The Company's technology is used to all transrenal nucleic acids (Tr-NA). The Company�� urine-based test addresses market needs, such as women�� healthcare-fetal medicine-down syndrome, infectious diseases, cancer testing, transplantation, drug development and monitoring of therapeutic outcomes, ultra-sensitive analytical and detection system, technologies for the collection, shipment and storage of urine specimens, and transrenal nucleic acid extraction, and instrumentation/system platform.
On January 18, 2011, the Company entered into an asset purchase agreement pursuant to which the Company acquired a hybridoma able to produce a monoclonal antibody targeting the NPM1 biomarker. On February 8, 2011, the Company entered into a sublicense agreement with MLL Munchner Leukamielabor (MLL). In July, 2011, the Company entered into a sublicense agreement with Fairview Health Services (Fairview) for NPM1 patent rights.
In October 2011, the Company entered into a license agreement pursuant to which the Company licensed the patent rights to a specific gene mutation with respect to chronic lymphoblastic leukemia. On December 12, 2011, the Company entered into a license agreement pursuant to which the Company licensed the patent rights to hairy cell leukemia biomarkers. On February 1, 2012, the Company acquired the clinical laboratory improvement amendments (CLIA) laboratory assets of MultiGEN Diagnostics, Inc. (MultiGEN).
Advisors' Opinion:- [By Roberto Pedone]
TrovaGene (TROV) is a development stage molecular diagnostic company focused on the development and marketing of urine-based nucleic acid tests for patient/disease screening and monitoring. This stock closed up 6% to $10.02 in Friday's trading session.
Friday's Volume: 712,000
Three-Month Average Volume: 183,106
Volume % Change: 294%From a technical perspective, TROV ripped higher here into all-time high territory with heavy upside volume. This stock has been uptrending strong for the last month and change, with shares soaring higher from its low of $5.75 to its new all-time high of $10.20. During that move, shares of TROV have been making mostly higher lows and higher highs, which is bullish technical price action. That move has also been accompanied by bullish upside volume flows.
Traders should now look for long-biased trades in TROV as long as it's trending above its recent breakout level of $8.83, and then once it sustains a move or close above its all-time high of $10.20 with volume that hits near or above 183,106 shares. If we get that move soon, then TROV will set up to enter new all-time high territory, which is bullish technical price action. Some possible upside targets off that move are $13 to $15.
- [By David Goodboy]
Fortunately, diagnostic issues may soon be a thing of the past. Several publicly traded companies are currently making great strides in the field of medical diagnostics, and my favorite company right now in that arena is TrovaGene (Nasdaq: TROV).
No comments:
Post a Comment